Core Insights - The 2026 Dazhou Eastern Economic Development Zone's first Innovation and Entrepreneurship Competition, themed "Intelligent Gathering, Dream Rising," was successfully held, marking a significant event for local innovation and entrepreneurship [1][2] Group 1: Event Overview - The competition was co-hosted by the Dazhou Eastern Economic Development Zone and Sichuan Dazhou Steel Group, featuring notable speakers including academicians and industry experts [1][3] - The event attracted 92 innovative projects from various regions, with 32 high-quality projects advancing to the finals, setting records for participation and project quality [2][3] Group 2: Industry Focus - The competition targeted four core industrial clusters: modern steel, new energy storage, chemical industry, and intelligent manufacturing, aligning with the region's industrial development needs [2][4] - The Dazhou Eastern Economic Development Zone is focusing on three main industries: steel and supporting industries, intelligent manufacturing, and chemicals/new materials, with significant investments in infrastructure and projects [4][5] Group 3: Economic Impact - During the 14th Five-Year Plan, the Dazhou Eastern Economic Development Zone implemented 55 major projects with an investment of 42.2 billion yuan, achieving an annual fixed asset investment growth rate of over 40% [4] - The region's industrial output value is projected to increase from 1.48 billion yuan in 2022 to 23.9 billion yuan in 2024, significantly enhancing its contribution to the city's economy [4] Group 4: Supportive Environment - The Dazhou Eastern Economic Development Zone offers competitive advantages such as the lowest industrial water prices among key parks in Sichuan and Chongqing, and anticipated reductions in electricity costs [5][6] - The zone emphasizes a service-oriented approach to business, aiming to create a favorable business environment that supports enterprise development [5][6] Group 5: Future Prospects - The competition established a new model for regional collaboration, integrating global innovation resources with local industrial strengths, and aims to create a unique brand for Dazhou's innovation events [6] - Future plans include a comprehensive service model for project incubation and support, enhancing the synergy between the "Dongsheng Cup" brand and local industry to foster continuous innovation [6]

公司于2026年1月5日收到合富香港出具的《关于提前终止减持计划暨减持结果的告知函》，合富香 港自2025年12月24日至2025年12月31日期间内，通过集中竞价方式减持公司股份3,980,000股，占公司总 股本的0.9999%，以上减持已达到合富香港资金需求，合富香港决定提前终止本次减持计划，以表达对 公司未来发展的信心及支持。 合富中国的公告显示，2025年12月24日至2025年12月31日，合富香港通过集中竞价减持3,980,000 股，减持总金额99,193,707元。 中国经济网北京1月6日讯 合富中国(603122.SH)昨晚发布控股股东提前终止减持计划暨减持股份结 果公告。 本次减持计划实施前，合富中国控股股东合富（香港）控股有限公司（简称"合富香港"）持有公司 股票218,937,885股，占公司总股本的55.0022%，上述股份全部来源于公司IPO前取得，均为无限售流通 股。 公司于2025年12月3日披露了《合富（中国）医疗科技股份有限公司控股股东减持股份计划公告》 （公告编号：2025-065），合富香港计划通过大宗交易方式和集中竞价交易方式减持公司股份数量合计 不超过7,961, ...

本报记者 谷业凯 工作人员在位于四川省稻城县的子午工程二 超临界二氧化碳发电机组。 中核集团中国核动力研究设计院供图(新华社发) 期进行设备运维。 新华社记者 江宏景摄 位于广东省东莞市的中国散裂中子源。 新华社记者 毛思倩摄 数据来源：科技部等 广东江门，地下700米深处，我国牵头的中微子实验装置发布首个物理成果。中国科学院院士王贻芳相 信："未来几十年，它会持续产出重大成果。" 贵州六盘水，全球首台商用超临界二氧化碳发电机组成功商运。在中核集团首席科学家黄彦平看 来："科技创新需要敢于突破的勇气。" 从基础研究到关键核心技术攻关，从场景牵引到应用赋能……中国经济动能更足、活力尽显。 习近平总书记强调："中国式现代化要靠科技现代化作支撑，实现高质量发展要靠科技创新培育新动 能。"2025年底举行的中央经济工作会议提出，"坚持创新驱动，加紧培育壮大新动能。" 培育壮大新动能，既是当下所需，也是未来所系。新年伊始，各地区各部门加快促进新动能集聚、新产 业壮大，因地制宜发展新质生产力，为高质量发展注入持久动力。 延伸产业链条，拓宽竞争赛道 扩围提质建设国际科技创新中心 京津冀、长三角、粤港澳大湾区，是引领全国高质 ...

你是否想象过平行时空的存在？ 复旦大学大数据学院副教授魏忠钰带领的Fudan DISC团队以现实为镜构建出由大模型智能体驱动的"硅 基人社会" 这个模拟世界由超千万的真实用户池支撑能够模拟社会群体活动倾听世界各地、各行各业的声音辅助政 府、企业做出更科学的决策 这就是他们研发的大模型驱动的社会模拟器——SocioVerse 从社交媒体传播模拟到服务社会决策，千万"硅基人"社会如何构建？ 参与过社会实践或行业调研的人，大多经历过这样的场景：在各个群里发放问卷，请求填写，甚至附上 红包。一番辛苦后，往往也只能拿到几百份结果。 而在更为广泛的社会，政府如何制定政策？公司如何优化迭代产品？投资顾问如何预测行业趋势？这些 决策都离不开大规模的社会调查，过程更是费时费力。 能否建构一个由大模型智能体驱动的"硅基人"社会，面向社会调查的需求，实现有问必答、有求必应， 想要多少数据就有多少数据的理想调查平台呢？DISC团队推出的社会模拟世界模型——SocioVerse，正 是面向这一需求而生。 成立于2016年的DISC团队，并不是第一个想到用大模型来进行社会模拟的课题组。斯坦福大学、加州 大学和清华大学等高校早已有学者开展 ...

Group 1 - The core viewpoint of the news is that Furuimei Medical has seen a stock price increase of 5.17%, reaching 74.05 yuan per share, with a trading volume of 291 million yuan and a turnover rate of 1.73%, resulting in a total market capitalization of 19.621 billion yuan [1] - Furuimei Medical, established on December 26, 2001, and listed on January 20, 2010, is primarily engaged in the production and sales of drugs in the liver disease sector, as well as instrument research and sales, and medical services [1] - The revenue composition of Furuimei Medical includes 67.57% from equipment and technology, 27.47% from pharmaceuticals, 4.30% from medical services, and 0.65% from other sources [1] Group 2 - According to data from the top ten holdings of funds, Hongtu Innovation Fund holds a significant position in Furuimei Medical, with 157,700 shares, accounting for 4.32% of the fund's net value, making it the ninth largest holding [2] - The Hongtu Innovation Healthcare Stock Fund (010434) has a current scale of 272 million yuan and has achieved a year-to-date return of 27.97%, ranking 1956 out of 4189 in its category [2] - The fund manager, Liao Xinghao, has been in position for 4 years and 45 days, with the fund's total assets amounting to 804 million yuan, achieving the best return of 81.61% and the worst return of -3.87% during his tenure [2]

Group 1 - Hubei is accelerating the establishment of a nationally influential technology innovation hub, enhancing its innovation capabilities to support the construction of a strong technology nation [1][3] - The discovery of a key gene that enables rice to withstand high temperatures has been recognized as a significant scientific breakthrough, providing new strategies for cultivating high-quality, heat-resistant rice [3][4] - Hubei has established a robust matrix of high-energy scientific forces, including a national laboratory and numerous key laboratories, contributing to its leadership in various research fields [4][5] Group 2 - Hubei's comprehensive technology innovation index has increased by 6.98 percentage points since 2020, ranking first in Central China and among the top in the nation [5][8] - The province has initiated the construction of provincial-level manufacturing pilot platforms, fostering a collaborative ecosystem for research and innovation among over 300 enterprises, universities, and research institutions [8][10] - The "Sharp Knife" project has successfully transformed 42 technological achievements into products, with a significant portion achieving international advanced levels [7][10] Group 3 - Hubei's industrial enterprises' R&D institution coverage has risen from 12.96% in 2020 to 31.8%, indicating a strong focus on innovation [12] - The number of technology-based small and medium-sized enterprises in Hubei has surged from 7,439 at the end of the 13th Five-Year Plan to 46,532, ranking fourth in the nation [12][13] - Hubei aims to become a crucial strategic support point for the rise of Central China, with a strong emphasis on technology innovation as the primary driving force for development [13]

根据北交所最新披露的信息，2025年12月31日，海南百迈科医疗科技股份有限公司IPO的状态从已受理 变更为已问询。 根据北交所最新披露的信息，2025年12月31日，海南百迈科医疗科技股份有限公司IPO的状态从已受理 变更为已问询。 ...

不久前，随着"贝小护"和"贝小慧"的上线，北大深圳医院AI智能体"贝家族"扩容，此外还有门诊全流程云陪 诊智能体"贝大夫"和运动处方AI智能体"贝小康"。截至目前，该院落地应用的AI应用场景达到70余个，一个 以患者为中心、"贝家族"为核心、数据为驱动的数智医疗新模式正加速成型。 走进宝安区辖属公立医院或社康中心，AI辅助诊断、病历分析、智能机器人等"AI+医疗"应用场景正悄然改 变着患者的就医体验，带来更高效、更个性化的医疗服务。 北大深圳医院医学影像科智慧医院应用场景。(北大深圳医院提供) 深圳商报记者赵鸿飞 一人住院，不必担心全家受累；仅用5分钟，AI就能生成出院小结；AI助力，产检超声检查提速——在深 圳，这些曾经的就医梦想，如今正通过AI技术"照进"现实。作为医疗高质量发展与智慧城市建设齐头并进的 城市，截至2025年3月，深圳已有450个人工智能产品走进深圳各级医疗机构。其中，临床医疗服务类404个， 医院管理类29个，公共卫生管理类4个，科教研辅助类2个，支撑环境类8个。 从基层社康到三甲医院，从诊前预防到诊中治疗再到术后康复，AI正悄悄重构深圳医疗服务的每个环节，深 圳市民看病更省心、更便捷， ...

Group 1 - President Xi Jinping's New Year message emphasizes the importance of innovation for high-quality development, resonating with the logistics industry, particularly with companies like Yunmanman that leverage AI to improve efficiency in freight matching [5] - The agricultural sector is highlighted as a key area for technological empowerment, with companies collaborating with research institutions to introduce new vegetable varieties and modern farming techniques, thereby increasing production efficiency and farmer income [6] - The cultural and technology integration is identified as a core strategy for the film industry in Nanjing, aiming to enhance the quality of cultural content and promote local stories through innovative formats like micro-short films [8] Group 2 - The healthcare sector is encouraged to focus on grassroots medical services, with professionals committing to provide accessible healthcare and community support, reflecting the broader goal of improving public health and well-being [14] - The women's development sector is set to implement a comprehensive plan to enhance the welfare of women and children, focusing on education, economic empowerment, and legal rights, which aligns with the national development goals [12] - Community governance initiatives are being strengthened to improve local services and enhance the quality of life for residents, showcasing a commitment to modernizing community management and engagement [11]

Group 1 - Xunfei Medical Technology (02506) increased by over 5.2% after shareholders committed not to reduce their holdings until December 29, 2026 [1] - Yimei International Holdings (01870) rose nearly 4% as its subsidiary's independent energy storage project was included in Guangdong's energy construction plan for 2025 [1] - Yituo Co., Ltd. (00038) slightly decreased by 0.35%, focusing on overseas business expansion and aiming to create a world-class brand [1] - Damai Entertainment (01060) surged over 5.5%, with the 2025 New Year film box office surpassing 5 billion yuan, marking a new high in eight years [1] Group 2 - Meilian Holdings (02671) fell over 18% on its second day of trading, dropping below its IPO price of 7.1 HKD [2] - Tianli International Holdings (01773) increased by over 4.4% as the Ministry of Education plans to advance AI in education [2] - Xuanwu Cloud (02392) rose by 0.87% after a major shareholder agreed to extend the lock-up period for their shares [2] - Ganfeng Lithium (01772) dropped nearly 5% due to allegations of insider trading [2] Group 3 - Boke Vision Cloud-B (02592) increased by 3.38% after a major shareholder extended the lock-up period for their shares [3] Group 4 - Yingsi Intelligent (03696) surged over 11% on its second day of trading, with a significant increase in share price from the IPO [4] - The company has developed over 20 clinical or IND application assets using its AI platform, with a total contract value of up to 2.1 billion USD [4] Group 5 - Intel (INTC.US) rose by 1.69% after Nvidia purchased 5 billion USD worth of Intel shares [5] - The global market for advanced driver assistance systems (ADAS) and autonomous driving sensors is projected to reach 61 billion USD by 2035 [6] - NIO (NIO.US) increased by 3% as it announced the global launch of its 2026 model P7+ [6] - Baidu (BIDU.US) rose by 4.39% after announcing a partnership with a logistics company to provide high-precision mapping services [6]